FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug application for its dual-antibody...
Search results for "drug treatment"
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple antihypertensive drug—were published on...
VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?
VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity
It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.
The Siren in Your Body: Why Enduring Pain is a Risk to Your Heart and Mind
"Pain is a warning siren of the body and can itself be a disease," says Director Lee Eui-sang of Yeosu Aeyang Hospital.
A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment
The treatment landscape for metastatic breast cancer is undergoing a significant shift.
Statins: Are the Side Effects Real? New Research Challenges Common Fears
"Many people hesitate to take cholesterol medication because of side effects they’ve heard about through the...
Breaking the Resistance: New Cause for Glioblastoma Recurrence Identified
Glioblastoma is widely regarded as the most aggressive and devastating form of brain cancer.
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
"Wegovy is a No": A Comprehensive Look at Olympic Doping and Detection Technology
As the 2026 Milan-Cortina d'Ampezzo Winter Olympics continue, the world of sports is once again focused on the thin...